Thermo Fisher Scientific | TMO - Zahlungsmittel Und Äquivalente





Zahlungsmittel Und Äquivalente Veränderung Datum
Abbott USD 6.8B 1.72B 2026-03
Agilent USD 1.76B 49M 2026-06
Becton, Dickinson and Co. USD 708M 105M 2026-06
Bio Techne USD 264.71M 54.89M 2026-06
Bio-Rad Laboratories USD 517M 9.8M 2026-06
Boston Scientific USD 539M 914M 2026-06
Bruker USD 184.9M 51.5M 2026-06
Charles River Laboratories USD 192.02M 195K 2026-06
Danaher USD 4.35B 1.35B 2026-06
Dentsply International USD 239M 49M 2026-06
Edwards Lifesciences USD 2.9B 500M 2026-06
General Electric Aerospace USD 9.35B 1.64B 2026-06
Henry Schein USD 157M 19M 2026-06
Illumina USD 1.09B 329M 2026-03
Intuitive Surgical USD 8.63B 646.3M 2026-06
IQVIA Holdings USD 1.91B 38M 2026-06
Laboratory Of America USD 141.8M 839.3M 2026-06
Medtronic USD 1.69B 258M 2026-06
Mettler Toledo International USD 51.38M 9.19M 2026-06
Myriad Genetics USD 115.2M 9.2M 2026-06
Olympus JPY 147.24B 93.98B 2025-09
OraSure Technologies USD 160.58M 16.38M 2026-06
Quest Diagnostics USD 626M 233M 2026-06
Repligen USD 606.78M 24.13M 2026-06
Revvity USD 1.02B 162.62M 2026-06
Stryker USD 3.39B 513M 2026-06
Thermo Fisher Scientific USD 3.25B 6.6B 2026-03
Veracyte USD 299.52M 36.38M 2026-06
Waters USD 539M 77M 2026-06
Zimmer Biomet Holdings USD 410M 14.2M 2026-06